EFFECTS OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES IN PATIENTS AT HIGH RISK OF ADVANCED LIVER FIBROSIS: POST HOC ANALYSES FROM THE DECLARE- TIMI 58 TRIAL

Jan Oscarsson, Monika Huhn,Ingrid Am Gause-Nilsson,Stephen D. Wiviott,Filipe A. Moura,John P. H. Wilding,Simona Cernea,Luc Van Gaal,Avivit Cahn,Deepak L. Bhatt,Darren K. McGuire,Peter A. Johansson,C. David Sjostrom

HEPATOLOGY（2023）

Cited 0|Views27
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined